deltatrials
Terminated PHASE1 INTERVENTIONAL 2-arm NCT04845321

VNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers

Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of VNRX-9945 in Healthy Adult Volunteers

Sponsor: Novotech (Australia) Pty Limited

Conditions Healthy Volunteers
Interventions Placebo for VNRX-9945 VNRX-9945
Updated 7 times since 2021 Last updated: Jun 4, 2025 Started: Jun 23, 2021 Primary completion: Oct 31, 2021 Completion: Oct 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Part 2 terminated, unrelated to safety.

Other terminated trials from Novotech (Australia) Pty Limited

More terminations from Novotech (Australia) Pty Limited

Other Healthy Volunteers trials with similar outcome

Browse all Healthy Volunteers trials

This PHASE1 trial investigates Healthy Volunteers and is currently terminated or withdrawn. Novotech (Australia) Pty Limited leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshotActive Not Recruiting~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotTerminated~Jul 2025 – present · 12 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Jul 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Jul 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Jul 2022 — Jul 2024 [monthly]

    Terminated PHASE1

    Status: Active Not Recruiting → Terminated

  5. Dec 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

  1. Sep 2021 — Dec 2021 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  2. May 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Novotech (Australia) Pty Limited
  • Venatorx Pharmaceuticals, Inc.
Data source: Venatorx Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations